156 related articles for article (PubMed ID: 17658777)
1. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.
Van Quaquebeke E; Mahieu T; Dumont P; Dewelle J; Ribaucour F; Simon G; Sauvage S; Gaussin JF; Tuti J; El Yazidi M; Van Vynckt F; Mijatovic T; Lefranc F; Darro F; Kiss R
J Med Chem; 2007 Aug; 50(17):4122-34. PubMed ID: 17658777
[TBL] [Abstract][Full Text] [Related]
2. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II.
Zhu H; Huang M; Yang F; Chen Y; Miao ZH; Qian XH; Xu YF; Qin YX; Luo HB; Shen X; Geng MY; Cai YJ; Ding J
Mol Cancer Ther; 2007 Feb; 6(2):484-95. PubMed ID: 17308047
[TBL] [Abstract][Full Text] [Related]
3. New anticancer agents.
Weiss GR; Burris HA; Eckardt JR; Fields S; O'Rourke T; Rodriguez GI; Rothenberg ML
Cancer Chemother Biol Response Modif; 1994; 15():130-51. PubMed ID: 7779583
[No Abstract] [Full Text] [Related]
4. Synthesis and anticancer activities of 6-amino amonafide derivatives.
Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
[TBL] [Abstract][Full Text] [Related]
5. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Mijatovic T; Mahieu T; Bruyère C; De Nève N; Dewelle J; Simon G; Dehoux MJ; van der Aar E; Haibe-Kains B; Bontempi G; Decaestecker C; Van Quaquebeke E; Darro F; Kiss R
Neoplasia; 2008 Jun; 10(6):573-86. PubMed ID: 18516294
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, Quantum-Chemical Calculations and Cytotoxic Activity of 1,8-Naphthalimide Derivatives with Non-Protein Amino Acids.
Marinov MN; Naydenova ED; Momekov GT; Prodanova RY; Markova NV; Voynikov YT; Stoyanov NM
Anticancer Agents Med Chem; 2019; 19(10):1276-1284. PubMed ID: 30848212
[TBL] [Abstract][Full Text] [Related]
7. Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.
Sami SM; Dorr RT; Sólyom AM; Alberts DS; Remers WA
J Med Chem; 1995 Mar; 38(6):983-93. PubMed ID: 7699715
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
9. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
[TBL] [Abstract][Full Text] [Related]
10. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
11. Analogues of amonafide and azonafide with novel ring systems.
Sami SM; Dorr RT; Alberts DS; Sólyom AM; Remers WA
J Med Chem; 2000 Aug; 43(16):3067-73. PubMed ID: 10956214
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths.
Tomczyk MD; Byczek-Wyrostek A; Strama K; Wawszków M; Kasprzycki P; Walczak KZ
Med Chem; 2019; 15(5):550-560. PubMed ID: 30207241
[TBL] [Abstract][Full Text] [Related]
13. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
14. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.
Innocenti F; Iyer L; Ratain MJ
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):596-600. PubMed ID: 11259359
[TBL] [Abstract][Full Text] [Related]
16. New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.
Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Domínguez MT; Pozuelo JM; Abradelo C; Rey-Stolle MF; Yuste M; Báñez-Coronel M; Lacal JC
J Med Chem; 2004 Mar; 47(6):1391-9. PubMed ID: 14998328
[TBL] [Abstract][Full Text] [Related]
17. Molecular modelling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors.
Filosa R; Peduto A; Micco SD; Caprariis Pd; Festa M; Petrella A; Capranico G; Bifulco G
Bioorg Med Chem; 2009 Jan; 17(1):13-24. PubMed ID: 19058969
[TBL] [Abstract][Full Text] [Related]
18. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel C4-benzazole naphthalimide derivatives with potent anti-tumor properties against murine melanoma.
Lu YT; Chen TL; Chang KS; Chang CM; Wei TY; Liu JW; Hsiao CA; Shih TL
Bioorg Med Chem; 2017 Jan; 25(2):789-794. PubMed ID: 27939348
[TBL] [Abstract][Full Text] [Related]
20. Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502).
Hariprakasha HK; Kosakowska-Cholody T; Meyer C; Cholody WM; Stinson SF; Tarasova NI; Michejda CJ
J Med Chem; 2007 Nov; 50(23):5557-60. PubMed ID: 17939651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]